Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

IFN-tau exhibits potent suppression of human papillomavirus E6/E7 oncoprotein expression.

Johnson JA, Hochkeppel HK, Gangemi JD.

J Interferon Cytokine Res. 1999 Oct;19(10):1107-16.

PMID:
10547150
2.

Molecular characterization of the hdm2-p53 interaction.

Böttger A, Böttger V, Garcia-Echeverria C, Chène P, Hochkeppel HK, Sampson W, Ang K, Howard SF, Picksley SM, Lane DP.

J Mol Biol. 1997 Jun 27;269(5):744-56.

PMID:
9223638
3.

Identification of novel mdm2 binding peptides by phage display.

Böttger V, Böttger A, Howard SF, Picksley SM, Chène P, Garcia-Echeverria C, Hochkeppel HK, Lane DP.

Oncogene. 1996 Nov 21;13(10):2141-7.

PMID:
8950981
4.

The effect of recombinant human interferon alpha B/D compared to interferon alpha 2b on SIV infection in rhesus macaques.

Schellekens H, Niphuis H, Buijs L, Douw van der Krap P, Hochkeppel HK, Heeney JL.

Antiviral Res. 1996 Aug;32(1):1-8.

PMID:
8863990
5.

Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C.

Jakschies D, Zachoval R, Müller R, Manns M, Nolte KU, Hochkeppel HK, Horisberger MA, Deicher H, Von Wussow P.

Hepatology. 1994 Apr;19(4):857-65.

PMID:
8138257
6.

MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon.

Roers A, Hochkeppel HK, Horisberger MA, Hovanessian A, Haller O.

J Infect Dis. 1994 Apr;169(4):807-13.

PMID:
7510764
7.

Cross-species antiviral activity of a recombinant human alpha-interferon hybrid.

Ghaffar A, Mayer EP, Barnhart DC, Pyo S, Szymaniec S, Hochkeppel HK, Gangemi JD.

Ann N Y Acad Sci. 1992 Jun 16;653:314-22. Review. No abstract available.

PMID:
1320843
8.

Effective natural interferon-alpha therapy in recombinant interferon-alpha-resistant patients with hairy cell leukemia.

von Wussow P, Pralle H, Hochkeppel HK, Jakschies D, Sonnen S, Schmidt H, Müller-Rosenau D, Franke M, Haferlach T, Zwingers T, et al.

Blood. 1991 Jul 1;78(1):38-43.

9.

Correlation of the antiproliferative effect and the Mx-homologous protein induction by IFN in patients with malignant melanoma.

Jakschies D, Hochkeppel HK, Horisberger MA, Deicher H, von Wussow P.

J Invest Dermatol. 1990 Dec;95(6 Suppl):238S-241S.

PMID:
1701809
10.

The human intracellular Mx-homologous protein is specifically induced by type I interferons.

von Wussow P, Jakschies D, Hochkeppel HK, Fibich C, Penner L, Deicher H.

Eur J Immunol. 1990 Sep;20(9):2015-9.

PMID:
2120071
11.

The interferon-induced Mx-homologous protein in people with symptomatic HIV-1 infection.

von Wussow P, Jakschies D, Block B, Tschechne B, Schedel I, Horisberger MA, Hochkeppel HK, Deicher H.

AIDS. 1990 Feb;4(2):119-24.

PMID:
2328094
12.

9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections.

Gangemi JD, Cozens RM, De Clercq E, Balzarini J, Hochkeppel HK.

Antimicrob Agents Chemother. 1989 Nov;33(11):1864-8.

13.

The immunomodulatory effects of interferon-gamma on mature B-lymphocyte responses.

Jurado A, Carballido J, Griffel H, Hochkeppel HK, Wetzel GD.

Experientia. 1989 Jun 15;45(6):521-6. Review.

PMID:
2500358
14.
15.

Antiviral activity of a novel recombinant human interferon-alpha B/D hybrid.

Gangemi JD, Lazdins J, Dietrich FM, Matter A, Poncioni B, Hochkeppel HK.

J Interferon Res. 1989 Apr;9(2):227-37.

PMID:
2541210
16.

Enhanced antiproliferative action of interferon targeted by bispecific monoclonal antibodies.

Alkan SS, Towbin H, Hochkeppel HK.

J Interferon Res. 1988 Feb;8(1):25-33.

PMID:
2452847
17.

Early viral proteins as autoantigens. Evidence from JC virus large T antigen.

Stoner GL, Ryschkewitsch CF, Walker DL, Soffer D, Braun DG, Hochkeppel HK, Webster HD.

Ann N Y Acad Sci. 1988;540:665-8. No abstract available.

PMID:
2849911
18.

Predominance of capsular polysaccharide type 5 among oxacillin-resistant Staphylococcus aureus.

Fournier JM, Bouvet A, Boutonnier A, Audurier A, Goldstein F, Pierre J, Bure A, Lebrun L, Hochkeppel HK.

J Clin Microbiol. 1987 Oct;25(10):1932-3.

20.

Monoclonal antibodies to the multienzyme enniatin synthetase. Production and use in structural studies.

Billich A, Zocher R, Kleinkauf H, Braun DG, Lavanchy D, Hochkeppel HK.

Biol Chem Hoppe Seyler. 1987 May;368(5):521-9.

PMID:
3620105
21.

Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8.

Hochkeppel HK, Braun DG, Vischer W, Imm A, Sutter S, Staeubli U, Guggenheim R, Kaplan EL, Boutonnier A, Fournier JM.

J Clin Microbiol. 1987 Mar;25(3):526-30.

22.

Antagonism of interferon induction in spleen and adherent peritoneal cells of mice by the lipophilic antiviral muramyl peptide MTP-PE.

Meyer T, Dietrich FM, Walker MR, Hochkeppel HK.

J Interferon Res. 1986 Jun;6(3):183-8.

PMID:
2427620
23.
26.

Biological activities of human recombinant interferon alpha/beta targeted by anti-Epstein-Barr virus monoclonal antibodies.

Miescher-Granger S, Hochkeppel HK, Braun DG, Alkan SS.

FEBS Lett. 1985 Jan 1;179(1):29-33.

27.

Antiviral and antiproliferative effects of interferons delivered via monoclonal antibodies.

Alkan SS, Miescher-Granger S, Braun DG, Hochkeppel HK.

J Interferon Res. 1984 Summer;4(3):355-63.

PMID:
6208296
28.

Inducibility of human beta-interferon gene in mouse L-cell clones.

Hauser H, Gross G, Bruns W, Hochkeppel HK, Mayr U, Collins J.

Nature. 1982 Jun 24;297(5868):650-4.

PMID:
6178033
29.

Monoclonal antibody against human IFN-gamma.

Hochkeppel HK, de Ley M.

Nature. 1982 Mar 18;296(5854):258-9. No abstract available.

PMID:
6174871
30.
31.

Demonstration of HIFN-beta in the liver of patients undergoing HIFN-beta treatment.

Müller R, Hochkeppel HK, Klein H.

FEBS Lett. 1981 Oct 26;133(2):194-6. No abstract available.

32.

Monoclonal antibodies against human fibroblast interferon.

Hochkeppel HK, Menge U, Collins J.

Eur J Biochem. 1981 Sep 1;118(3):437-42.

33.

Monoclonal antibodies against human fibroblast interferon.

Hochkeppel HK, Menge U, Collins J.

Nature. 1981 Jun 11;291(5815):500-1. No abstract available.

PMID:
6164930
34.

Evidence for cross-linking of polyribonucleotides with 4'-aminomethyl-4,5',8-trimethylpsoralen hydrochloride.

Hochkeppel HK, Gordon J.

Biochemistry. 1979 Jun 26;18(13):2905-10. No abstract available.

PMID:
383143
35.

Significant changes in 16 S RNA conformation accompanying assembly of the 30 S ribosome in vitro.

Hochkeppel HK, Craven GR.

J Mol Biol. 1977 Jul 15;113(4):623-34. No abstract available.

PMID:
911390
36.
37.

RNA of the small subunit of the Escherichia coli ribosome With additional protein binding sites Characterization of the structure by electron micro.

Hochkeppel HK, Gordon J, Brack C.

FEBS Lett. 1977 May 15;77(2):277-280. doi: 10.1016/0014-5793(77)80251-2. No abstract available.

38.
39.
40.

A method of preparing Escherichia coli 16 S RNA possessing previously unobserved 30 S ribosomal protein binding sites.

Hochkeppel HK, Spicer E, Craven GR.

J Mol Biol. 1976 Feb 25;101(2):155-70. No abstract available.

PMID:
772215

Supplemental Content

Loading ...
Support Center